6-imidazol-1-yl-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(4-methylimidazol-1-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(1-methylpyrazol-3-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-(2H-tetrazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-(1,3-thiazol-5-yl)-2,7-naphthyridin-1-amine

C144H121N37OS — CID 158669295

About 6-imidazol-1-yl-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(4-methylimidazol-1-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(1-methylpyrazol-3-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-(2H-tetrazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-(1,3-thiazol-5-yl)-2,7-naphthyridin-1-amine

6-imidazol-1-yl-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(4-methylimidazol-1-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(1-methylpyrazol-3-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-(2H-tetrazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-(1,3-thiazol-5-yl)-2,7-naphthyridin-1-amine (PubChem CID 158669295) has the molecular formula C144H121N37OS and a molecular weight of 2417.88 g/mol. Its IUPAC name is 6-imidazol-1-yl-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(4-methylimidazol-1-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(1-methylpyrazol-3-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-(2H-tetrazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-(1,3-thiazol-5-yl)-2,7-naphthyridin-1-amine.

Molecular Properties

• Compound Name: 6-imidazol-1-yl-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(4-methylimidazol-1-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(1-methylpyrazol-3-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-(2H-tetrazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-(1,3-thiazol-5-yl)-2,7-naphthyridin-1-amine
• PubChem CID: 158669295
• Molecular Formula: C144H121N37OS
• Molecular Weight: 2417.88 g/mol
• Exact Mass: 2416.03
• IUPAC Name: 6-imidazol-1-yl-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(4-methylimidazol-1-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(1-methylpyrazol-3-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-(2H-tetrazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-(1,3-thiazol-5-yl)-2,7-naphthyridin-1-amine
• SMILES: Cc1cc(-c2ccc(CNc3nccc4cc(-c5ccn(C)n5)ncc34)cc2)ccn1.Cc1cc(-c2ccc(CNc3nccc4cc(-c5cncs5)ncc34)cc2)ccn1.Cc1cc(-c2ccc(CNc3nccc4cc(-c5nn[nH]n5)ncc34)cc2)ccn1.Cc1cc(-c2ccc(CNc3nccc4cc(-c5nnc(C)o5)ncc34)cc2)ccn1.Cc1cc(-c2ccc(CNc3nccc4cc(-n5ccnc5)ncc34)cc2)ccn1.Cc1cc(-c2ccc(CNc3nccc4cc(-n5cnc(C)c5)ncc34)cc2)ccn1
• InChI: InChI=1S/2C25H22N6.C24H20N6O.C24H20N6.C24H19N5S.C22H18N8/c1-17-13-20(7-10-26-17)19-5-3-18(4-6-19)15-29-25-22-16-28-24(14-21(22)8-11-27-25)23-9-12-31(2)30-23;1-17-11-21(7-9-26-17)20-5-3-19(4-6-20)13-29-25-23-14-28-24(12-22(23)8-10-27-25)31-15-18(2)30-16-31;1-15-11-19(7-9-25-15)18-5-3-17(4-6-18)13-28-23-21-14-27-22(12-20(21)8-10-26-23)24-30-29-16(2)31-24;1-17-12-20(6-8-26-17)19-4-2-18(3-5-19)14-29-24-22-15-28-23(30-11-10-25-16-30)13-21(22)7-9-27-24;1-16-10-19(6-8-26-16)18-4-2-17(3-5-18)12-29-24-21-13-28-22(23-14-25-15-30-23)11-20(21)7-9-27-24;1-14-10-17(6-8-23-14)16-4-2-15(3-5-16)12-26-21-19-13-25-20(22-27-29-30-28-22)11-18(19)7-9-24-21/h3-14,16H,15H2,1-2H3,(H,27,29);3-12,14-16H,13H2,1-2H3,(H,27,29);3-12,14H,13H2,1-2H3,(H,26,28);2-13,15-16H,14H2,1H3,(H,27,29);2-11,13-15H,12H2,1H3,(H,27,29);2-11,13H,12H2,1H3,(H,24,26)(H,27,28,29,30)
• InChIKey: IDTCIXLJOWDGDI-UHFFFAOYSA-N
• XLogP: 29.42
• TPSA: 463.93 Ų
• H-Bond Donors: 7
• H-Bond Acceptors: 38
• Rotatable Bonds: 30
• Heavy Atoms: 183
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2417.88
LogP ≤ 5	29.42
H-Bond Donors ≤ 5	7
H-Bond Acceptors ≤ 10	38

Frequently Asked Questions

What is the IUPAC name of 6-imidazol-1-yl-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(4-methylimidazol-1-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(1-methylpyrazol-3-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-(2H-tetrazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-(1,3-thiazol-5-yl)-2,7-naphthyridin-1-amine?

The IUPAC name of 6-imidazol-1-yl-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(4-methylimidazol-1-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(1-methylpyrazol-3-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-(2H-tetrazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-(1,3-thiazol-5-yl)-2,7-naphthyridin-1-amine (CID 158669295) is 6-imidazol-1-yl-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(4-methylimidazol-1-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(1-methylpyrazol-3-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-(2H-tetrazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-(1,3-thiazol-5-yl)-2,7-naphthyridin-1-amine.

What is the SMILES notation for 6-imidazol-1-yl-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(4-methylimidazol-1-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(1-methylpyrazol-3-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-(2H-tetrazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-(1,3-thiazol-5-yl)-2,7-naphthyridin-1-amine?

The canonical SMILES for 6-imidazol-1-yl-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(4-methylimidazol-1-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(1-methylpyrazol-3-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-(2H-tetrazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-(1,3-thiazol-5-yl)-2,7-naphthyridin-1-amine is Cc1cc(-c2ccc(CNc3nccc4cc(-c5ccn(C)n5)ncc34)cc2)ccn1.Cc1cc(-c2ccc(CNc3nccc4cc(-c5cncs5)ncc34)cc2)ccn1.Cc1cc(-c2ccc(CNc3nccc4cc(-c5nn[nH]n5)ncc34)cc2)ccn1.Cc1cc(-c2ccc(CNc3nccc4cc(-c5nnc(C)o5)ncc34)cc2)ccn1.Cc1cc(-c2ccc(CNc3nccc4cc(-n5ccnc5)ncc34)cc2)ccn1.Cc1cc(-c2ccc(CNc3nccc4cc(-n5cnc(C)c5)ncc34)cc2)ccn1.

What is the InChIKey of 6-imidazol-1-yl-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(4-methylimidazol-1-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(1-methylpyrazol-3-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-(2H-tetrazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-(1,3-thiazol-5-yl)-2,7-naphthyridin-1-amine?

The InChIKey is IDTCIXLJOWDGDI-UHFFFAOYSA-N. The full InChI is InChI=1S/2C25H22N6.C24H20N6O.C24H20N6.C24H19N5S.C22H18N8/c1-17-13-20(7-10-26-17)19-5-3-18(4-6-19)15-29-25-22-16-28-24(14-21(22)8-11-27-25)23-9-12-31(2)30-23;1-17-11-21(7-9-26-17)20-5-3-19(4-6-20)13-29-25-23-14-28-24(12-22(23)8-10-27-25)31-15-18(2)30-16-31;1-15-11-19(7-9-25-15)18-5-3-17(4-6-18)13-28-23-21-14-27-22(12-20(21)8-10-26-23)24-30-29-16(2)31-24;1-17-12-20(6-8-26-17)19-4-2-18(3-5-19)14-29-24-22-15-28-23(30-11-10-25-16-30)13-21(22)7-9-27-24;1-16-10-19(6-8-26-16)18-4-2-17(3-5-18)12-29-24-21-13-28-22(23-14-25-15-30-23)11-20(21)7-9-27-24;1-14-10-17(6-8-23-14)16-4-2-15(3-5-16)12-26-21-19-13-25-20(22-27-29-30-28-22)11-18(19)7-9-24-21/h3-14,16H,15H2,1-2H3,(H,27,29);3-12,14-16H,13H2,1-2H3,(H,27,29);3-12,14H,13H2,1-2H3,(H,26,28);2-13,15-16H,14H2,1H3,(H,27,29);2-11,13-15H,12H2,1H3,(H,27,29);2-11,13H,12H2,1H3,(H,24,26)(H,27,28,29,30).

What are the key properties of 6-imidazol-1-yl-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(4-methylimidazol-1-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(1-methylpyrazol-3-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-(2H-tetrazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-(1,3-thiazol-5-yl)-2,7-naphthyridin-1-amine?

6-imidazol-1-yl-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(4-methylimidazol-1-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(1-methylpyrazol-3-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-(2H-tetrazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-(1,3-thiazol-5-yl)-2,7-naphthyridin-1-amine has a molecular weight of 2417.88 g/mol, XLogP of 29.42, 30 rotatable bonds, 7 hydrogen bond donors, and 38 hydrogen bond acceptors.

Where does this data come from?

All data for 6-imidazol-1-yl-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(4-methylimidazol-1-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;6-(1-methylpyrazol-3-yl)-N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-(2H-tetrazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]-6-(1,3-thiazol-5-yl)-2,7-naphthyridin-1-amine is sourced from PubChem (CID 158669295), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).